Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for blood cancer patients in early drug trial

NCT ID NCT06768489

Summary

This early-stage study is testing a new drug, JNJ-79635322, when given alongside standard treatments for multiple myeloma, a type of blood cancer. The main goal is to find safe and effective dose levels for these drug combinations. Researchers will enroll about 140 participants with multiple myeloma to monitor side effects and see if the treatment helps control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Calvary Mater Newcastle Hospital

    RECRUITING

    Waratah, 2298, Australia

  • Carmel Medical Center

    RECRUITING

    Haifa, 3436212, Israel

  • Hadassah Medical Center

    RECRUITING

    Jerusalem, 9112001, Israel

  • Hosp Clinico Univ de Salamanca

    RECRUITING

    Salamanca, 37007, Spain

  • Hosp. Clinic de Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Monash Medical Centre

    RECRUITING

    Clayton, 3168, Australia

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, 3000, Australia

  • Sheba Medical Center

    RECRUITING

    Ramat Gan, 52621, Israel

  • St Vincents Hospital Melbourne

    RECRUITING

    Fitzroy, 3065, Australia

  • Tel Aviv Sourasky Medical Center

    RECRUITING

    Tel Aviv, 64239, Israel

  • UMC Utrecht

    RECRUITING

    Utrecht, 3584 CX, Netherlands

  • Universitair Medisch Centrum Groningen

    RECRUITING

    Groningen, 9713 GZ, Netherlands

  • VU Medisch Centrum

    RECRUITING

    Amsterdam, 1081 HV, Netherlands

  • Wollongong Hospital

    RECRUITING

    Wollongong, 2500, Australia

Conditions

Explore the condition pages connected to this study.